Evaluation of a modified 2-step diagnostic algorithm for human immunodeficiency virus type 1 utilizing an HIV-1/2 antigen/antibody immunoassay screen and an HIV nucleic acid amplification test

INTRODUCTION: A multi-test algorithm is routinely used for HIV-1 diagnosis. Guidelines recommend an HIV-1/2 antigen/antibody (Ag/Ab) immunoassay screen that reflexes reactive samples to an HIV-1/2 antibody differentiation immunoassay for confirmation. If negative or indeterminate antibody differentiation results are observed, an HIV nucleic acid amplification test (NAAT) is used to determine HIV status. An alternative algorithm in which screen reactive samples reflex to HIV NAAT has been proposed. The objective of this study was to compare the accuracy of the standard versus alternative algorithm for final HIV-1 interpretation. METHODS: A total of 392 remnant HIV-1 samples from routine testing at two Quest laboratories were tested using the cobas® HIV-1/HIV-2 Qualitative NAAT. Laboratory algorithm interpretations and TAT were evaluated between the two algorithms. RESULTS: The positive percent agreement (PPA) between the two algorithms was 95.3% (181/190) and negative percent agreement (NPA) was 100% (202/202). Discordant results were identified as HIV-1 positive by the current algorithm but negative by the alternative algorithm. Previously diagnosed positive patients undergoing treatment or re-testing could not be ruled out. Workflow analysis showed that the there is less hands-on time per sample for the HIV NAAT compared to the differentiation immunoassay, which may result in faster TAT depending on testing volumes. CONCLUSION: The data show the alternative algorithm is acceptable for HIV laboratory diagnosis in terms of analytical performance with minimal impact to TAT at our institution.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Virology
Published
2026-04-27
DOI
https://doi.org/10.1016/j.jcv.2026.105947
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of a modified 2-step diagnostic algorithm for human immunodeficiency virus type 1 utilizing an HIV-1/2 antigen/antibody immunoassay screen and an HIV nucleic acid amplification test

Kimberly Macias, Elizabeth M. Marlowe, Realegeno Susan, Meghan Starolis et al.
Journal of Clinical Virology
HIV Research and Treatment
article

Evaluation of a modified 2-step diagnostic algorithm for human immunodeficiency virus type 1 utilizing an HIV-1/2 antigen/antibody immunoassay screen and an HIV nucleic acid amplification test

Kimberly Macias, Elizabeth M. Marlowe, Realegeno Susan, Meghan Starolis, Tessa M Shates
article en

Abstract

INTRODUCTION: A multi-test algorithm is routinely used for HIV-1 diagnosis. Guidelines recommend an HIV-1/2 antigen/antibody (Ag/Ab) immunoassay screen that reflexes reactive samples to an HIV-1/2 antibody differentiation immunoassay for confirmation. If negative or indeterminate antibody differentiation results are observed, an HIV nucleic acid amplification test (NAAT) is used to determine HIV status. An alternative algorithm in which screen reactive samples reflex to HIV NAAT has been proposed. The objective of this study was to compare the accuracy of the standard versus alternative algorithm for final HIV-1 interpretation. METHODS: A total of 392 remnant HIV-1 samples from routine testing at two Quest laboratories were tested using the cobas® HIV-1/HIV-2 Qualitative NAAT. Laboratory algorithm interpretations and TAT were evaluated between the two algorithms. RESULTS: The positive percent agreement (PPA) between the two algorithms was 95.3% (181/190) and negative percent agreement (NPA) was 100% (202/202). Discordant results were identified as HIV-1 positive by the current algorithm but negative by the alternative algorithm. Previously diagnosed positive patients undergoing treatment or re-testing could not be ruled out. Workflow analysis showed that the there is less hands-on time per sample for the HIV NAAT compared to the differentiation immunoassay, which may result in faster TAT depending on testing volumes. CONCLUSION: The data show the alternative algorithm is acceptable for HIV laboratory diagnosis in terms of analytical performance with minimal impact to TAT at our institution.

Journal of Clinical VirologyVol. 184
Quest Diagnostics (United States) (US)
Roche Diagnostics
Good health and well-being
Openalex Percentile: Top 13%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.